Viewing StudyNCT03818997



Ignite Creation Date: 2024-05-06 @ 12:38 PM
Last Modification Date: 2024-10-26 @ 1:02 PM
Study NCT ID: NCT03818997
Status: WITHDRAWN
Last Update Posted: 2020-02-05
First Post: 2019-01-24

Brief Title: Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Organization Data

Organization: European Organisation for Research and Treatment of Cancer - EORTC
Class: NETWORK
Study ID: EORTC 1741-GITCG
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Leap Therapeutics Inc INDUSTRY
Hoffmann-La Roche INDUSTRY